-
Plk1 Control of p31comet in Mitotic Checkpoint Disassembly
2026-08-23
The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. By combining HeLa cell extracts, purified proteins, kinase inhibition, and an S102A mutant, the authors show how Plk1 phosphorylation restrains checkpoint silencing and prevents premature anaphase signaling.
-
Hesperadin: Aurora B Kinase Inhibitor Workflow
2026-08-22
Hesperadin provides a focused way to connect Aurora B inhibition with histone H3 dephosphorylation, chromosome segregation errors, cytokinesis failure, and polyploidization. This practical guide combines dose-response design, checkpoint-aware controls, and troubleshooting for reproducible cell cycle and cancer research assays.
-
Gemini Quaternary Ammonium Compounds: Study Insights
2026-08-22
This Bioorganic Chemistry study synthesized 16 novel gemini quaternary ammonium compounds and identified derivatives with activity across bacterial, biofilm, fungal, and viral models. Compounds 12 and 1 were especially notable for combining broad or selective antimicrobial activity with improved cytotoxicity profiles relative to octenidine and benzalkonium chloride comparators.
-
Viral RIPK3 Degradation Controls Inflammation
2026-08-21
Liu and colleagues identified a cowpox-virus protein family that recruits the host SCF ubiquitin-ligase machinery to degrade RIPK3, thereby reshaping necroptosis and viral pathogenesis. Comparative virology and mouse genetics showed that this viral inducer of RIPK3 degradation, or vIRD, is a major determinant of orthopoxvirus replication, inflammation, and mortality.
-
Hesperadin: Aurora B Kinase Inhibitor Workflow
2026-08-20
Hesperadin provides a practical way to connect Aurora B inhibition with histone H3 phosphorylation, chromosome segregation defects, cytokinesis failure, and polyploidization. This workflow emphasizes dose-and-time optimization, orthogonal readouts, and careful separation of Aurora B phenotypes from the Polo-like kinase 1 checkpoint mechanism described in the reference study.
-
Tolazoline and K+ Channels in Insulin Release
2026-08-20
The 1992 reference study showed that imidazoline compounds, including Tolazoline, stimulate insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells rather than simply by blocking α2-adrenoceptors. Its combined use of 86Rb efflux, whole-cell patch clamp, and pharmacological challenge experiments provides a strong framework for interpreting receptor-independent effects in islet function research.
-
GS-441524 Workflow for Prodrug LC–MS/MS Studies
2026-08-19
Build a practical GS-441524 workflow around solubility control, paired parent–metabolite measurements, and matrix-specific conversion experiments. The approach helps distinguish chemical release from biological disposition in antiviral and pharmacokinetic studies.
-
Recent Ibuprofen and Naproxen Synthesis Advances
2026-08-19
Ha and Paek’s review maps how ibuprofen and naproxen synthesis has progressed from classical multistep manufacturing routes toward asymmetric, catalytic, derivative-oriented, and continuous-flow approaches. Its practical value lies in showing how route design, stereochemical control, reagent selection, and process intensification influence the reproducibility and scalability of COX inhibitor research.
-
Hesperadin: Reading Aurora B Phenotypes
2026-08-18
Hesperadin is an Aurora B kinase inhibitor that reveals how mitotic errors become measurable cell-cycle phenotypes. This guide connects its pharmacology with mitotic checkpoint biology and shows how to distinguish Aurora B effects from checkpoint-complex disassembly mechanisms.
-
Deracoxib–Doxorubicin in Canine Mammary Cells
2026-08-18
This 2017 study examined whether deracoxib could reduce doxorubicin-associated injury in cultured normal canine mammary epithelial cells. Using viability, apoptosis, and nitrite assays, the authors linked deracoxib-mediated protection to reduced apoptosis and suppression of doxorubicin-related nitric oxide overproduction, while leaving open whether this effect preserves anticancer activity in tumor cells.
-
Z-DEVD-FMK: Caspase-3 Inhibitor Workflows
2026-08-17
Z-DEVD-FMK supports practical dissection of apoptotic, caspase, and calpain-dependent cell death in culture and neuroprotection models. Its cell permeability and irreversible activity make it useful for pathway validation, but its activity against several caspases requires careful controls before assigning effects specifically to caspase-3.
-
KDM4D, Iron Status, and MSC Quiescence
2026-08-17
The 2024 reference study identifies iron-dependent KDM4D demethylase activity as an epigenetic checkpoint that controls mesenchymal stem cell activation through the PIK3R3–PI3K-Akt-Foxo1 axis. Its findings connect iron deficiency with impaired bone marrow MSC mobilization and reduced bone mass, while pathway modulation provides a mechanistic route for partially reversing this phenotype.
-
A23187, Free Acid: Calcium Ionophore Guide
2026-08-16
A23187, free acid is a calcium ionophore used to raise intracellular Ca2+ and study calcium-dependent signaling, contraction, and cell death. Its model-specific effects include phosphoinositide hydrolysis, mitochondrial permeability transition-dependent apoptosis, ROS generation, and enhanced Zn2+ influx.
-
Schwartz 2022: Measuring Cancer Drug Responses In Vitro
2026-08-15
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different relationships between proliferative arrest and cell death. The work supports time-resolved, mechanistically aware in vitro drug-response experiments rather than relying on a single viability value.
-
α-Linolenic Acid Research Workflows
2026-08-14
Build reproducible ALA experiments for lipid flux, cardiovascular signaling, inflammation, and cancer biology without confusing omega-3 substrate effects with immune findings established for arachidonic acid. This practical guide covers stock preparation, assay design, cross-domain interpretation, and troubleshooting.